No headlines found.
Globe Newswire (Tue, 19-Nov 7:30 AM ET)
Globe Newswire (Thu, 14-Nov 4:15 PM ET)
Globe Newswire (Mon, 4-Nov 7:30 AM ET)
Globe Newswire (Thu, 31-Oct 7:30 AM ET)
Scorpius Holdings Announces Partnership with U.S. Biotech Company
Globe Newswire (Tue, 22-Oct 8:00 AM ET)
Globe Newswire (Wed, 2-Oct 8:00 AM ET)
Globe Newswire (Mon, 30-Sep 8:00 AM ET)
Scorpius Holdings Inc is an integrated contract development and manufacturing organization (CDMO) focused on rapidly advancing biologic and cell therapy programs to the clinic and beyond. It offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its state-of-the-art facilities.
Scorpius Holdings trades on the AMEX stock market under the symbol SCPX.
As of December 13, 2024, SCPX stock price declined to $0.30 with 302,982 million shares trading.
SCPX has a beta of 3.69, meaning it tends to be more sensitive to market movements. SCPX has a correlation of 0.04 to the broad based SPY ETF.
SCPX has a market cap of $1.30 million. This is considered a Sub-Micro Cap stock.
SCPX support price is $.30 and resistance is $.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SCPX shares will trade within this expected range on the day.